mianserin has been researched along with Atherosclerotic Parkinsonism in 2 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Excerpt | Relevance | Reference |
---|---|---|
"Rats treated with haloperidol at doses of 0." | 1.37 | Reversal of haloperidol-induced motor deficits by mianserin and mesulergine in rats. ( Haleem, DJ; Shireen, E, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shireen, E | 1 |
Haleem, DJ | 1 |
Korsgaard, S | 1 |
Friis, T | 1 |
1 trial available for mianserin and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Effects of mianserin in neuroleptic-induced parkinsonism.
Topics: Adult; Aged; Antipsychotic Agents; Dibenzazepines; Humans; Male; Mianserin; Middle Aged; Parasympath | 1986 |
1 other study available for mianserin and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Reversal of haloperidol-induced motor deficits by mianserin and mesulergine in rats.
Topics: Animals; Antipsychotic Agents; Catalepsy; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Ha | 2011 |